NCT04161248 2026-02-02
Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma
Canadian Cancer Trials Group
Phase EARLY_PHASE1 Recruiting
Clinical Trials
10 trialsNCT02992015 2025-03-07
Gemcitabine in Newly-Diagnosed Diffuse Intrinsic Pontine Glioma
University of Colorado, Denver
Phase EARLY_PHASE1 Completed
NCT03519308 2024-03-15
A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Terminated
NCT06204614 2024-01-12
Drug Screening Using IMD in Bladder Cancer
Brigham and Women's Hospital
Phase EARLY_PHASE1 Unknown
NCT02550327 2021-06-22
Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer
Baylor Research Institute
Phase EARLY_PHASE1 Completed
NCT01715142 2020-09-04
NEOPAX-001
Erasme University Hospital
Phase EARLY_PHASE1 Completed
NCT01276613 2019-05-02
Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Terminated
NCT02929797 2016-10-11
AKT
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1 Unknown
NCT02707315 2016-03-14
A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer
The Cooper Health System
Phase EARLY_PHASE1 Unknown
NCT01713218 2012-10-24
NEOPACHI-001
Erasme University Hospital
Phase EARLY_PHASE1 Unknown